| Go Pro | AZ1 Chatter | IMYO FYI | PicaTel | Tell your friends and family about INSTATEL & AZ1 |

With over 20 approved products and several under development, the Avastin® biosimilars market is projected to witness noteworthy growth over the coming years, claims Roots Analysis | #"Global Bevacizumab biosimilar market # Bevacizumab # Avastin # Bevacizumab Colon Cancer Drugs # Kidney Cancer Drugs # Lung Cancer Drugs # Ovarian Cancer Drugs # Pancreatic Cancer Drugs # cancer biosimilar drug market # Bevacizumab Market Opportunity"

News and Politics

With over 20 approved products and several under development, the Avastin® biosimilars market is projected to witness no

In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved